Eli Lilly plans to launch weight-loss drug in emerging markets this year
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, Chief Financial Officer Lucas Montarce said on Monday at the Leerink Partners Global Healthcare Conference.
Eli Lilly's Global Expansion Plan for Blockbuster Drug Mounjaro
Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, and Mexico by 2025. With 900 million potential patients, the company aims to meet growing global demand alongside competitor Novo Nordisk.
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday ...
The move positions Lilly as a competitive alternative to compounded weight-loss drugs, especially as the FDA cracks down on off-brand versions. Eli Lilly announced in a press release last week ...
The Associated Press on MSN8d
Popular weight-loss drugs get cheaper: Novo Nordisk and Eli Lilly cut pricesDanish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Last week, Eli Lilly said it would cut the monthly price ... pharmacies and other entities that have been allowed to make off-brand, cheaper copies of the drugs during the shortage will have ...
cheaper versions and spawned an alternative marketplace for off-brand weight-loss drugs. Now Novo Nordisk and Indianapolis-based rival Eli Lilly and Co. are seeking to capture the large market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback